(Q70597514)

English

Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388)

scientific article published on 01 April 1971

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

title

Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

D. H. Cowan

1

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5118686

retrieved

21 December 2023

D. E. Bergsagel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5118686

retrieved

21 December 2023

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed ID

5118686

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5118686

retrieved

21 December 2023

publication date

1 April 1971

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

published in

Cancer chemotherapy reports

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

volume

55

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

page(s)

175-181

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 October 2019

Identifiers

PubMed ID

5118686

1 reference

stated in

Europe PubMed Central

PubMed ID

5118686

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5118686%20AND%20SRC:MED&resulttype=core&format=json

(Q70597514)

Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)